Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,605 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06914726Enrolling by invitation
Cancer risk follow-up care for hereditary syndromes
This study tests a tool to help primary care doctors provide better cancer prevention care for people with hereditary breast and ovarian cancer (HBOC) or Lynch syndrome (LS). It aims to ensure you're up-to-date on recommended screenings and preventive steps.
Minneapolis, MinnesotaAges 18 years+ - NCT06889077Enrolling by invitation
QR code learning tool for nursing students
This study tests if QR codes in perioperative education materials help second-year nursing students learn better. You might join if you are a second-year nursing student at Gülhane Nursing Faculty.
AnkaraAges 18 years+ - NCT06725199Enrolling by invitation
NMR metabolomic study in fibromyalgia
This study uses a special MRI-like test (NMR) to look at chemical changes in the body of people with fibromyalgia. It aims to better understand the condition and could help find new ways to diagnose or treat it.
Istanbul, IstanbulAges 18–65 - NCT06649071Enrolling by invitation
Obesity classification and brain imaging study
This study looks at how obesity is classified and what brain imaging can show in people with obesity. It may help researchers understand different types of obesity and how they affect the brain.
Nanjing, JiangsuAges 20–65 - NCT06558292Enrolling by invitation
Virtual reality simulation to reduce stress for nursing students
This study tests whether a virtual reality practice session before clinical training can help reduce stress and anxiety. It is designed for second-year nursing students who have not yet taken the surgical nursing course.
AnkaraAges 18 years+ - NCT06358261Enrolling by invitation
Diabetes prevention study using a patient activation tool
This trial tests a tool that helps people with prediabetes take steps to prevent diabetes. If you are a patient at a specific Johns Hopkins clinic and use MyChart, you may be able to join.
Lutherville, MarylandAges 18 years+ - NCT05388019Enrolling by invitation
VAD clinic visit study for new and returning patients
This trial looks at how well a specialized, multidisciplinary clinic works for people who have a ventricular assist device (VAD) and compares new VAD patients with those who have already had standard follow-up visits. It may help improve how care and check-ins are organized after your VAD is implanted.
Boston, MassachusettsAges 18 years+ - NCT05341986Enrolling by invitation
ED tool to help prevent stroke in atrial fibrillation
This study tests an electronic decision-support tool used in the emergency department (ED) to help clinicians choose the safest way to prevent stroke when atrial fibrillation is newly found. It may help by improving how quickly and consistently stroke-prevention treatment is considered.
Portland, OregonAges 18 years+ - NCT05284513Enrolling by invitation
Care team study for families with high cholesterol
This study tests a “reach everyone” approach in primary care clinics to improve care for people with familial hypercholesterolemia (families with very high cholesterol). It may help families get recognized sooner and get the right follow-up.
Multiple Locations, PennsylvaniaAges 26 years+ - NCT05045222Enrolling by invitation
Reviewing health and costs after whole-exome genetic testing
This study looks at real-world health outcomes and costs after whole-exome genetic testing done through the Tapestry program. Your results—whether they find something or not—are used to understand what happens next and how care decisions may change.
Scottsdale, ArizonaAges 18 years+ - NCT03756649Enrolling by invitation
IBD biobank study for adults and young adults
This study collects and stores information and samples from people with inflammatory bowel disease (IBD) to help researchers learn more and improve care. Your participation mainly helps build a “biobank,” which can support future studies.
Rochester, MinnesotaAges 18–85 - NCT07776665RecruitingPhase 1
Study of a new medication in healthy volunteers
This trial tests a new medication (called enlicitide) in healthy volunteers to see how well it is absorbed by the body. The study aims to find the best formulation for future use. If you are generally healthy and meet the criteria, you may be eligible to participate.
Lincoln, NebraskaAges 19–55 - NCT06482073Recruiting
Genetic testing for suspected lung cancer
This study looks at genetic changes in people with suspected or high-risk lung cancer. It aims to use those results to guide more personalized treatment decisions.
Rochester, MinnesotaAges 18 years+ - NCT07788196RecruitingPhase 2
Adding anti-HER2 therapy after surgery for early-stage gastric cancer
This trial tests whether adding a targeted therapy (anti-HER2) to standard chemotherapy after surgery can improve outcomes for people with early-stage gastric cancer that has high HER2 levels. It aims to see if the combination is more effective than chemotherapy alone.
Xi'an, ShaanxiAges 18 years+ - NCT07786220Recruiting
How thinking and memory affect inhaler use in COPD
This study looks at whether memory and thinking skills affect how well people with COPD use their inhalers. It may help find ways to improve inhaler technique and make treatment more effective.
Timișoara, Timiș CountyAges 18–100 - NCT07787975Recruiting
Understanding genetic test results with RNA sequencing
This study uses a special test called RNA sequencing to find genetic causes of diseases when standard genetic tests didn't give answers. It might help you get a clearer diagnosis or find out if a genetic change actually causes your condition.
San Francisco, CaliforniaAges 2 years+ - NCT06940297RecruitingPhase 2
Dasatinib and quercetin with CAR-T therapy for relapsed or refractory multiple myeloma
This trial tests whether adding two drugs, dasatinib and quercetin, to CAR-T therapy can help people with multiple myeloma that has come back or not responded to past treatments. It aims to make the CAR-T cells work better and reduce side effects.
Rochester, MinnesotaAges 18 years+ - NCT07788118RecruitingPhase 1/Phase 2
A new car-t therapy for relapsed large b-cell lymphoma
This trial tests a new type of CAR-T cell therapy that may be better at remembering and attacking lymphoma cells. It is for people with large B-cell lymphoma that has not responded to standard treatments or has come back.
Hangzhou, ZhejiangAges 18–75 - NCT07554924RecruitingPhase 1/Phase 2
Gene therapy for newly diagnosed spinal muscular atrophy type I infants
This study tests SKG0201, a new gene therapy designed to treat spinal muscular atrophy type I (SMA type I), a rare genetic condition affecting muscle strength. The trial enrolls very young infants diagnosed with SMA type I to see if the treatment is safe and helps improve muscle function.
Beijing, Beijing MunicipalityAges Up to 6 months - NCT04239573Recruiting
Compare pancreatic cyst checkup programs and test markers
This study compares different ways to monitor pancreatic cysts and also measures blood or other test markers to see which approach is more helpful. It may help patients by finding the safest, most effective way to track certain cysts that could otherwise be hard to manage.
Birmingham, AlabamaAges 50–75 - NCT00344331Recruiting
Testing blood and MRI markers for Niemann-Pick type C
This study measures biochemical (blood/biologic) markers and may use clinical evaluation and MRI to better understand Niemann-Pick disease type C. It could help improve how the condition is tracked and understood over time.
Bethesda, MarylandAges 1 day–120 years - NCT06892548RecruitingPhase 1/Phase 2
Combination therapy for advanced lung cancer
This trial tests a new combination of two investigational drugs, BNT324 and BNT327, for people with advanced lung cancer that cannot be removed by surgery. It aims to see if the combination is safe and effective for different types of lung cancer, including non-small cell and small cell lung cancer.
Phoenix, ArizonaAges 18 years+ - NCT07709897RecruitingPhase 2
Preventing nausea & vomiting after surgery
This trial tests if adding HRS5580 to standard anti-nausea medicine works better to stop vomiting after surgery. You may qualify if you are at moderate-to-high risk for nausea after general anesthesia.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07735442Recruiting
Support program for seriously ill cancer patients in hospital
This trial tests a new way to better support hospitalized patients with advanced cancer. It aims to improve communication and care planning for those who are seriously ill and at high risk of not surviving their hospital stay at Brigham and Women's Hospital.
Boston, MassachusettsAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,605 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.